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s
iRNA-based therapeutics have great
potential to suppress pathogenic gene
expressions.1,2 Gene therapy can be
applied for various disease treatments
such as cancer, neurodegenerative dis-
eases, antiviral diseases, hematological dis-
eases and hereditary genetic disorders.3
However, progress of siRNA cancer therapy
relies on the development of safe and eﬀec-
tive delivery systems. The usage of novel
nanocarriers oﬀers substantial advantages
including the prevention of degradation,
possibility of delivering high concentrations
of siRNA into tumor tissues, speciﬁc target-
ing, and controlled release.1
The development of novel nanocarriers
capable of delivering drugs to the organism
in an eﬃcient manner has attracted much
attention. Polymer- and liposome-based
nanoparticles are nowadays among the
most commonly used materials for gene
delivery.1,3,4 Recently, however, silica-based
materials have emerged as new candidates
for targeted drug delivery applications,5,6
which can oﬀer distinct advantages over
other materials. Silica is usually less toxic
compared to polycations.7 Porous silica ma-
terials have shown substantial beneﬁts in
terms of loading owing to their high poros-
ity (i.e., high surface area and high pore
volume), tunable pore size in the nanometer
regime, and vast surface functionalization
capabilities.8,9
Previous studies in this area have shown
the eﬀectiveness of silica-based materials
to transfer genes and anticancer drugs
into target cells. In particular, nanosized
silica particles (nonporous) were used for
the ﬁrst time as inorganic nonviral gene
delivery carriers by Kneuer et al. in 2000.10
Silica nanoparticles with diﬀerent sizes
(10100 nm) were modiﬁed with aminosi-
lanes to generate positive charges around
the surface, and the resultingmaterials were
able to condense and protect plasmid
DNA.10 The major advantage of using por-
ous silica materials compared to nonporous
ones is the possibility to bind biomolecules
either on the surface or within the pore and
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ABSTRACT Large pore mesoporous silica nano-
particles (LP-MSNs) functionalized with poly-
L-lysine (PLL) were designed as a new carrier
material for gene delivery applications. The
synthesized LP-MSNs are 100200 nm in dia-
meter and are composed of cage-like pores organized in a cubic mesostructure. The size of the
cavities is about 28 nm with an entrance size of 13.4 nm. Successful grafting of PLL onto the
silica surface through covalent immobilization was conﬁrmed by X-ray photoelectron
spectroscopy, solid-state 13C magic-angle spinning nuclear magnetic resonance, Fourier
transformed infrared, and thermogravimetric analysis. As a result of the particle modiﬁcation
with PLL, a signiﬁcant increase of the nanoparticle binding capacity for oligo-DNAs was
observed compared to the native unmodiﬁed silica particles. Consequently, PLL-functionalized
nanoparticles exhibited a strong ability to deliver oligo DNA-Cy3 (a model for siRNA) to Hela
cells. Furthermore, PLL-functionalized nanoparticles were proven to be superior as gene
carriers compared to amino-functionalized nanoparticles and the native nanoparticles. The
system was tested to deliver functional siRNA against minibrain-related kinase and polo-like
kinase 1 in osteosarcoma cancer cells. Here, the functionalized particles demonstrated great
potential for eﬃcient gene transfer into cancer cells as a decrease of the cellular viability of the
osteosarcoma cancer cells was induced. Moreover, the PLL-modiﬁed silica nanoparticles also
exhibit a high biocompatibility, with low cytotoxicity observed up to 100 μg/mL.
KEYWORDS: mesoporous silica nanoparticles . poly-L-lysine . gene delivery .
siRNA . cellular uptake
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achieve much higher loadings,7 with potential for
codelivery.11 Thus far, mesoporous silicamaterials with
small pore size (<3 nm) were reported as potential
carriers to deliver siRNA7,11,12 and DNA.7 In these
approaches, due to the small pore size, the genes
remain coated only on the external surface of the
mesoporous silica materials. Recently, Li et al. showed
that large amount of double stranded salmon DNA
(20250 bp with an average chain length of 50 nm)
could be adsorbed within the pore (2.7 nm) of mag-
netic mesoporous silica nanoparticles by optimizing
adsorption conditions.13
The importance of pore size of mesoporous silica
materials in gene adsorption was ﬁrst discussed by
Solberg et al.14 They proved that DNA adsorption was
dependent on the pore size. Subsequently, Gao et al.
used large pore (∼20 nm) mesoporous silica nano-
particles (70300 nm) to adsorb large plasmid DNA
(5256 bp).15 These authors achieved very high amounts
of adsorbed pDNA (9.7 μg/mg). Most of the pDNA was
adsorbed inside the mesopores, conﬁrming the im-
portance of larger pore size to increase adsorption.
Similarly, Kim et al. showed the beneﬁt of using large
pore mesoporous silica as a DNA carrier in order to
achieve high plasmid DNA loadings and enhanced
protection of DNA against DNase degradation.16 This
study conﬁrmed that large pore mesoporous silica
materials were indeed more eﬀective gene delivery
carriers as compared to the small pore counterparts. In
addition, mesoporous silicon microsize particles with
large pore size have also been used to produce sus-
tained siRNA delivery. The large pores were used to
adsorb siRNA-liposomes complex.17 However, submic-
rometer size materials (nanoparticles) are clearly pre-
ferred compared to the micrometer size particles. First,
micrometer size particles (larger than 200 nm) are
cleared faster from blood circulation.15,18 Second, nano-
size particles lead to higher cellular uptake compared to
the micrometer size particles.4,16
From these results, we see the potency of using large
pore mesoporous silica nanoparticles (LP-MSNs) as
carriers for siRNA delivery. However, the successful
application of LP-MSNs for delivery of nucleic acid-
based drugs requires surface modiﬁcation of the silica
in order to generate suﬃcient binding aﬃnity for the
negatively charged nucleic acids. Various techniques
have been implemented to place positively charged
functional groups in silica materials, either through
noncovalent interactions or by covalent bonding.
Amino-silanes and polycation polymers have been
widely used as chemical agents to modify the silica
surfaces.7,10,11,19 Especially, PLL is one of the ﬁrst poly-
cations that were used as carriers for gene delivery.20
Although PLL alone can eﬀectively deliver genes into
target cells,21 a combination with mesoporous silica
could oﬀer supplementary advantages.11,19,22
Li et al. used electrostatic interactions to form a
complex of PLL and silica nanoparticles2325 and ap-
plied this system as a vehicle for plasmid DNA
delivery.23 They showed that such a complex could
eﬃciently bind genes and protect them from enzy-
matic degradation, and, consequently, deliver anti-
sense oligonucleotides (ODNs) selectively into cells.24
However, simple adsorption of PLL could not be used
to uniformly modify silica particles larger than 60 nm,
possibly due to the unfavorable surface energy of large
silica particles.23 Lunn et al.26 used surface-initiated
polymerization ofN-carboxyanhydrides (NCAs) to graft
peptide (PLL and poly-L-alanine) on the surface of
amine-functionalized mesoporous silica materials
(MCM-41, SBA-15, and KIT-6). However, this functiona-
lization procedure resulted in signiﬁcant reduction of
the porosity of the silica particles and pore blockage at
high peptide loading. Consequently, the loading capa-
city of the particles was dramatically decreased. Diﬀer-
ently, Kar et al.27 reported the use of a “grafting to”
approach by combining NCA polymerization and click
chemistry to synthesize PLL-grafted SBA-15. Thismeth-
od enables the graftingwith precisemolecular weights
and maintains the materials porosity. Yet, this ap-
proach remains time-consuming in order to accom-
plish the multistep synthesis procedure.
In this work, we develop a novel and facile method
to attach PLL onto LP-MSNs to produce LP-MSN-P
(poly-L-lysine functionalized large pore mesoporous
silica nanoparticles) and use it as a carrier to deliver
siRNA into cancer cells. We ﬁrst prepared LP-MSNs as
the hosts which were subsequently functionalized by
grafting of epoxysilane (3-glycidoxypropyl trimethox-
ysilane (3-GPS)) to yield LP-MSN-E, and then LP-MSN-P.
Amine (APTES) functionalized LP-MSNs (LP-MSN-A)
were also synthesized for comparison. The inﬂuences
of the diﬀerent surface functionalization (PLL, amine,
and unfunctionalized) on DNA adsorption, cell uptake,
cytotoxicity and biological function are then substan-
tiated. It was found that LP-MSN-P has much higher
aﬃnity for nucleic acids than unfunctionalized LP-MSNs.
LP-MSN-P is proved to be farmore eﬃcient in supporting
cancer cells transfection as compared to the LP-MSN-A
and unfunctionalized silica nanoparticles. At a low con-
centration (<100 μg/mL), LP-MSN-P has low cytotoxicity.
Moreover, we also demonstrate that the LP-MSN-P can
eﬀectively deliver siRNA into cancer cells and silence the
oncogenes.
RESULTS AND DISCUSSION
Synthesis of Large Pore Mesoporous Silica Nanoparticles
(LP-MSNs). LP-MSNs with a 3-D cubic mesostructure were
synthesized following amethod previously reported.15
These nanoparticles are expected to be promising for
drug and gene delivery, because a cubic pore network
with a high degree of pore interconnectivity allows
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superior mass transfer compared to one-dimensional
channel-like structures and are more resistant to pore
blocking.9,28 The synthesis strategy for the LP-MSNs
lies on using a dual surfactant system, that is, a
combination of triblock copolymer (F127), acting as
the cubic pore structure-directing agent, and a fluoro-
carbon surfactant (FC-4) to control particle growth.
Images of the thus-obtained LP-MSNs are shown in
Figure 1. The scanning electron microscopy (SEM)
images of LP-MSNs shown in Figure 1A confirm the
formation of spherical particles with a fairly narrow
particle size distribution in the range of 100200 nm.
The transmission electron microscopy (TEM) image
(Figure 1B) indicates the presence of large pores
(around 20 nm) with cage-like structure organized in
a typical cubic mesostructure in each of the particles.
The specific use of FC-4 permits a fine control of the
formation of MSNs in order to achieve the desired
particle size (<200 nm). Conversely, the absence of
FC-4 causes the production of mesoporous silica with
micrometer size particles (812 μm) as it is the case for
standard FDU-12-type materials.9,29
Nitrogen physisorption results of the sample
LP-MSNs (Supporting Information, FigureS1) demonstrate
a type IV isothermwith H2 hysteresis loop at high relative
pressures indicating theexistenceof largemesoporeswith
cage-like structures.29 Thepore sizewas determinedusing
theBroekhoﬀdeBoer (BdB)method30 considering sphe-
rical shape pores, although deviation from ideal spherical
pore morphology is possible here. The cavity size of
LP-MSNs was evaluated to be 27.9 nm, and the entrance
pore sizewas 13.4 nm. TheBET surface areaof the samples
was313m2/g, and theporevolumewasaround1.09cm3/g
(Table 1). These data are in line with the results from TEM
analysis. The formation of an extra large cavity size and
large entrance size is attributed to the use of a low
temperature synthesis method (10 C) followed by rela-
tively high hydrothermal temperatures (140 C). It is
believed that the usage of low temperature enhances
the penetration of the swelling agent TMB (1,3,5-
trimethylbenzene) into the hydrophobic core of the
micelles during synthesis, which ultimately results in an
extra enlargement of pore size (27.9 nm).15,29,31 The use of
high hydrothermal treatment temperature of 140 C
contributed in the widening of the entrance pore size
above 13.4 nm.
Owing to the small spherical particle size and the
large pore size (large unit cell), the mesostructure
symmetry of the sample is diﬃcult to determine by
powder X-ray analysis (XRD).15,3234 The small particle
size of LP-MSNs (<200 nm) with large pore size
(∼28 nm) only allows a small number of unit cells in
each single particle (i.e., the size of coherent scattering
domains is small). Because of the limited size of
ordered pore domains, small-angle X-ray scattering
(SAXS) analysis of LP-MSNs shows only one resolved
peak (Supporting Information, Figure S2), in agree-
ment with other reports on mesoporous nanoparti-
cles.15,35 Nevertheless, TEM investigations conﬁrmed
the existence of typical cubic mesostructure in LP-MSNs.
Functionalization of LP-MSNs with PLL (LP-MSN-P) and APTES
(LP-MSN-A). The surface modification of mesoporous
silica is an essential requirement for the material to
be used as a delivery vehicle to transfer genes (DNA/
siRNA) into targeted cells. A selective surface functio-
nalization can introduce positive charges on the silica
surface, which in turn permits electrostatic interactions
with negatively charged DNA/siRNA. One of the meth-
ods to achieve this is to coat the silica with polycation
species such as PLL. The above synthesized LP-MSNs
Figure 1. SEM images of (A) LP-MSNs, (C) LP-MSN-E, (E)
LP-MSN-P, and (G) LP-MSN-A and TEM images of (B) LP-MSNs,
and (D) LP-MSN-E, (F) LP-MSN-P, and (H) LP-MSN-A.
TABLE 1. Physicochemical Properties of theNative LP-MSNs
and Functionalized Materials
pore size (nm)
sample BET (m2/g) pore volume (mL/g) cavity entrance zeta potential (mV)
LP-MSNs 313 1.09 27.9 13.4 17.3
LP-MSN-A 155 0.63 24.6 11.3 þ3.23
LP-MSN-P 171 0.64 24.1 11.8 þ1.90
A
RTIC
LE
HARTONO ET AL . VOL. 6 ’ NO. 3 ’ 2104–2117 ’ 2012
www.acsnano.org
2107
were modified with PLL and APTES to produce the
materials labeled as LP-MSN-P and LP-MSN-A, respec-
tively. This study aims also at comparing the effective-
ness of PLL and amine functionalization, as both of
them are the most common functional groups to be
used in gene carrier surface modification.10,2325,36
The procedure employed for the functionalization
of LP-MSNs with PLL is illustrated in Scheme 1. First, (1)
3-GPS was anchored to the silica surface of the spheres
by grafting, similarly to other alkoxysilanes, through a
standard silanoxane coupling mechanism.37 The reac-
tion of the functional silane with the silanol groups
present on the silica surface was performed in toluene
under reﬂux condition, yielding LP-MSN-E. (2) PLL was
then attached to silica via nucleophilic addition to the
epoxyde sites of the 3-GPS. The interaction between
PLL and the epoxysilane is ensured by the nucleophilic
attack of the nonbonding electron pair of nitrogen
atoms on strained acidic carbons in the epoxy ring
causing the ring to open.38 After proton migration, the
required product is obtained (LP-MSN-P).38 (3) The
resulting composites of LP-MSNs and PLL can then
be used as a DNA/siRNA carrier. In addition, amine
functionalized LP-MSN (LP-MSN-A) was prepared by
standard grafting of APTES in toluene.16
Figure 1 panels C, E, and G show SEM images of the
functionalized LP-MSNs samples (LP-MSN-E, LP-MSN-P,
and LP-MSN-A, respectively). The images reveal that
the functionalization process does not aﬀect the
spheroid-like morphology of LP-MSNs. Furthermore,
the TEM images (Figure 1 D, F, and H) also indicate that
the cubic pore structure, pore size, particle size, and
particle morphology are all well preserved for the
functionalized particles. Most importantly, the nitro-
gen sorption data show that the functionalization of
LP-MSNs with diﬀerent organic species (APTES and
PLL) did not result in pronounced obstruction of the
materials porosity (Supporting Information, Figure S1).
Clearly, the organic functionalized LP-MSNs (LP-MSN-A
and LP-MSN-P) still preserved the structure of the
native silica material (LP-MSNs). However, the attach-
ment of the organics aﬀected speciﬁc surface area,
pore volume, and pore size, these values being smaller
for the functionalized samples (Table 1). The main
reason is the presence of the organic compound both
on the external and internal surface of the silica9,38 The
functionalization of LP-MSNs with PLL (14 kDa)
caused a pore diameter reduction from 13.4 to
11.8 nm. This result is in good agreementwith previous
research by Karl et al. who showed that functionaliza-
tion of SBA-15 by using diﬀerent molecular weights of
PLL (from 3 to 6 kDa) caused a pore diameter reduc-
tion of ca. 12 nm.27 TG-DTA analysis of LP-MSN-P
(Supporting Information, Figure S3) conﬁrms the PLL
attachment on the LP-MSNs. The analysis shows amass
loss of 7% (the percent weight does not include the
percent weight of epoxysilane). On the other hand,
amine functionalization resulted in a pore size de-
crease of LP-MSNs to 11.3 nm. On the basis of the
thermogravimetric analysis (TGA) analysis, the loading
amount of amine silane grafted into LP-MSNs was
almost double than that of PLL with a weight loss up
to 13 wt %. Both functionalization procedures (PLL and
APTES) also aﬀected the uniformity of the mesopore
cavities resulting in wider pore size distributions
(Supporting Information, Figure S1).
Scheme 1. Schematic Illustration of the Steps for the Poly-L-lysine Grafting and Gene Loading into LP-MSN-P
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Nature of the PLL and APTES Attachment onto LP-MSNs. The
PLL groups should provide the silica surface with
sufficient quantity of positive charges to achieve rela-
tively strong interactions with siRNA. Yet at the same
time, the amount of PLL groups should remain low
enough in order to limit toxicity exposure. A low
molecular weight of PLL (14 kDa) was used because
lower molecular weights of polycations are known to
induce lower toxicity.7,39 A previous study on the
toxicity of PLL with different molecular weights
(2.9 and 27.4 kDa) indicates that low molecular weight
PLL (2.9 kDa) has lower cytotoxicity vs human cell lines
as compared to higher molecular weight PLL.40 As
shown in Table 1, the introduction of PLL which
contains amine moieties produced positive charges
on the silica surface, resulting in a positive LP-MSN-P
potential value (þ1.9 mV as compared to LP-MSNs
with 17.3 mV). The grafting of the aminosilane
(APTES) on the silica surface also produced a positively
charged surface (þ3.23 mV). The positive charges are
expected to permit adsorption of negatively charged
DNA and siRNA, as discussed below.
The X-ray photoelectron spectroscopy (XPS) ana-
lyses of four diﬀerent samples (LP-MSNs, LP-MSN-E,
LP-MSN-P, andLP-MSN-A) provideevidenceof the attach-
ment of the organic compounds on the silica surface
(Figure 2 and Table 2). The spectra of the functionalized
LP-MSNs show a strong C1s peak which reﬂects the
increasing amount of organics on the silica surface.
Speciﬁcally, the incorporation of APTES and PLL results
in an intense peak associated to N1s. The atomic
composition of these samples is given in Table 2. Small
content of C1s in LP-MSNs may be ascribed to residual
surfactant species.9 The introduction of the epoxysi-
lane (3-GPS) into silica leads to an increase in atomic
percent of C concentration (13.7%). The grafting with
PLL further increases the carbon percentage (14.80%)
and the N1s atom signal emerges with a concentra-
tion of 2.47%. The atomic weight percentage of N in
LP-MSN-A is double than that of LP-MSN-P. This result
is in good agreement with the TGA analysis, and it
explains why LP-MSN-A has higher zeta potential value
than LP-MSN-P (Table 1).
Figure 3 shows the solid state 13C charge-polarized
magic angle spinning nuclear magnetic resonance
(CP-MAS NMR) spectra of LP-MSN-E, LP-MSN-P, and
LP-MSN-A. The data conﬁrm successful anchoring of
the organic compounds on the silica surface. The pres-
ence of epoxy-silane (3-GPS) can directly be judged from
two distinct peaks C5 and C6 with chemical shifts of
50.64 and 43.45 ppm, respectively (Figure 3A). These
peaks reveal the presence of the carbon atoms of the
epoxide ring.41 The other peaks corresponding to
C1 (7.88 ppm), C2 (22.18 ppm), C3 and C4 (72.56 ppm)
also corroborate the chemical structure of 3-GPS.41
Figure 3B represents the 13C CP-MAS NMR spectra of
LP-MSN-P. It can be seen that the two peaks at 43.45
and 50.64 disappeared, which is an indication that the
epoxy ring was opened and the PLL was properly
anchored.41 The presence of PLL can be seen from
the carbonyl (CdO) peak at 173.61 ppm.42 The other
peaks observed for CR (53.76 ppm), Cβ (27.24 ppm), Cγ
(26.12 ppm), Cδ (30.24 ppm), and Cε (39.83 ppm) also
belong to PLL.42,43 Some peaks at 9.01 (C1), 22.56 (C2),
and 72.75 (C3þC4) ppm can be attributed to remaining
3-GPS. The chemical shifts of the 13C NMR resonances
of the LP-MSN-E and LP-MSN-P samples are compiled
in Table 3. Similarly, the covalent attachment of the
aminosilane (APTES) is proven by three peaks with the
chemical shift 11.02, 26.10, and 44.34 ppm (Figure 3 C),
which can be ascribed to the carbon atoms C1, C2,
and C3 (i.e., SiOSiC1C2C3NH2).9
The sequence of epoxysilane grafting followed by
PLL attachment can also be veriﬁed by transmis-
sion FTIR. Supporting Information, Figure S4 shows
the spectra obtained from three diﬀerent samples:
LP-MSNs, LP-MSN-E, and LP-MSN-P. Silanol (SiOH),
SiOSi, and OSiObands from the parent material
(LP-MSNs) are observed at 3400, 1094, and 470 cm1,
respectively.26,44 The main characteristic band as-
signed to the epoxy group at around 1150 cm1 is,
however, overlapped by the strong absorption of silica.
Alkyl CH stretching and the corresponding bending
vibrations are detected at 2944, 1343, and 1465 cm1,
respectively.44 Furthermore, the presence of the PLL
on the surface of the silica samples can be identiﬁed
Figure 2. XPS spectra of (A) LP-MSNs, (B) LP-MSN-E, (C)
LP-MSN-P, and (D) LP-MSN-A.
TABLE 2. Elemental Composition of LP-MSNs and
Functionalized Materials
element content (atom %)a
sample C1s O1s Si2p N1s
LP-MSNs 1.30 69.02 29.67
LP-MSN-E 13.17 61.16 25.67
LP-MSN-P 14.80 58.16 24.57 2.47
LP-MSN-A 24.94 46.29 23.81 4.96
a XPS analysis.
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through the presence of an amide-I peak at 1680 cm1
and the amide-II peak at 1540 cm1. The amide-I is due
to CdO stretching, while the amide II arises from CN
stretching and NH bending.45 These two peaks con-
ﬁrm the attachment of the PLL on the LP-MSNs.
DNA Adsorption and Cellular Uptake. First, the affinity of
LP-MSNs and its functionalized counterparts to 21-
nucleotide long (oligo) DNA (a model for siRNA) was
measured by adsorption. Figure 4 shows the results of
the oligo DNA adsorption in LP-MSNs and the functio-
nalized forms (LP-MSN-A and LP-MSN-P). Interestingly,
LP-MSN-P shows a very high adsorption capacity for
the oligo DNA (57 μg/mg or 1.56 nmol per 175 μg
LP-MSN-P). Noteworthy, the adsorption amount of
LP-MSN-P was almost five times higher compared to
the polyethyleneimine functionalized MSNs (PEI-MSN)
materials reported previously.12 The presence of PLL
increases the particle affinity toward the gene. It is
believed that the synergy between the large pore size
of LP-MSNs and the PLL functionalization contributed
to this significant difference. It has been found before
that large plasmid DNA (5256 bp) can be internalized
within LP-MSNs with an entrance pore size of 5.7 nm.15
Thus, it is expected that LP-MSN-P with a larger en-
trance size (11.8 nm) can adsorb oligo DNA with 21
base pairs in higher amounts compared to the small
pore PEI-MSNs.
It is also interesting to note that the adsorption
capacity of LP-MSN-P was almost equal to that of
LP-MSN-A, although LP-MSN-P has lower amine con-
centration and a lower zeta potential value. There are
several reasons to explain such an enhanced perfor-
mance of LP-MSN-P compared to LP-MSN-A. First, the
interaction between LP-MSN-A and oligo-DNA are
mainly electrostatic, whereas the strong interactions
between LP-MSN-P and the oligo-DNA are originating
from the combination of electrostatic interactions and
speciﬁc binding of PLL to the AT (adeninethymine)
sequences of DNA. Indeed, previous reports have
conﬁrmed that other binding forces come into
play between polycations and DNA strands besides
electrostatic forces, that is, the selectivity of PLL
for A-T sequences and poly-L-arginine for GC
(guaninecytosine) sequences.4648 The association
of the electrostatic interactions and selective binding
confers LP-MSN-P strong aﬃnity to oligo-DNA, result-
ing in increased adsorption amounts. Second, the
major advantage of LP-MSN-P in comparison to
LP-MSN-A in terms of interfacial contact with oligo-DNA
is the presence of PLL, which possesses a 3-D polymeric
TABLE 3. Summary of Resonance of 13C CP NMR Spectra
for LP-MSN-E and LP-MSN-P Samples
LP-MSN-E C1 C2 C3 C4 C5 C6
chemical shift (ppm) 7.88 22.18 72.56 72.56 50.64 43.45
LP-MSN-P CdO CR Cβ Cγ Cδ Cε
chemical shift (ppm) 173.61 53.76 27.24 26.12 30.34 39.83
Figure 4. Oligo DNA adsorption against LP-MSNs, LP-MSN-A,
and LP-MSN-P.
Figure 3. Solid state 13 C CP NMR spectra of (A) LP-MSN-E,
(B) LP-MSN-P, (C) LP-MSN-A.
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structure. The existence of numerous amine groups
along the PLL chains generates multiple accessible
reaction sites. This 3-D reactive structure provides
several attachment sites for the genes.49 In contrary,
functionalization with APTES only introduces linear
and short aminoalkyl chains on the silica surface that
induce a relatively planar surface structure. This type of
organization seems to aﬀord a more restricted envir-
onment for DNA/siRNA attachment,50 therefore in-
creasing steric hindrance between the DNA molecules,
and thus limiting their adsorption. As a result ofmultiple
accessible attachments, LP-MSN-P keeps a very high
adsorption capacity.
The cell internalization capacity of functionalized
LP-MSNs was also studied in the case of cancer cells
(HeLa cells). To adequately follow adsorption and the
cell internalization process, oligo-DNA was labeled
with cyanine dye (Cy3). Figure 5 illustrates the cell
uptake study of LP-MSNs and the functionalized
equivalents. It is observed that there is no Cy3
signal from native LP-MSNs. In contrast, the modiﬁed
LP-MSNs (LP-MSN-A and LP-MSN-P) revealed dye signals.
Among the functionalized materials, LP-MSN-P pro-
duced the strongest Cy3 signals. The strong signals of
the oligo DNA-LP-MSN-P complex were found in most
of the cancer cells which indicates thatmost of the cells
have been transfected. The strong signal is generated
from the high concentration of the complexes which
canbe internalizedwithin the cells. In contrary, Figure 5
also shows that oligo DNA-LP-MSN-A did not give
equivalently strong signals, assuming that it was due
to the reduced internalization of oligo DNA-LP-MSN-A
complex. Figure 5 shows that the signal from the
LP-MSN-A complex is not distributed equally throughout
the cells. This result suggests that LP-MSN-A could not
be adequately internalized within most of the cells. It is
Figure 5. Cell uptake of LP-MSNs and functionalized counterparts. The cell up-take eﬃciency of LP-MSNs, LP-MSN-P, and
LP-MSN-A were examined by labeling the particles with a 21-nt oligo DNA conjugated with Cy-3. The oligo DNA-Cy3 (DNA-Cy3)
or LP-MSN-A alone is negative for Cy3 signal. LP-MSNs are unable to carry oligo DNA-Cy3 thus no Cy3 signal is observed.
LP-MSN-A with oligo DNA-Cy3 shows positive signal. LP-MSN-P is more eﬀective to adsorb DNA-Cy3 and has the strongest
Cy3 signal.
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thus obvious that LP-MSN-A is not as eﬀective as
LP-MSN-Pas a gene carrier for cancer cell uptake. Further-
more, the negatively charged native LP-MSNs could
not interact at all with the negatively charged cell
surface and did not undergo cell internalization, result-
ing in no signal detected.
Furthermore, the cellular uptake of Cy3-labeled
oligo DNA-LP-MSNs and functionalized counterparts
(LP-MSN-A and LP-MSN-P) into HeLa cells were as-
sessed by ﬂow cytometry (Figure 6 A) and confocal
microscopy (Figure 6 B). Flow cytometry analysis re-
veals that PLL and amine functionalization resulted
in a clear shift in the MFI (mean ﬂuorescent intensity).
The analysis consists of two parts: with quenching
treatment and without quenching treatment. The
results show clearly (Figure 6 A) that LP-MSN-P ex-
hibits the most strong ﬂuorescent signals and has a
highest percentage of positive cells (6070%) as
compared to the other two groups (amine modiﬁed
and nonmodiﬁed). Quenching treatment with DNase
I (as Cy 3 was conjugated to oligo DNA) only slightly
reduced the ﬂuorescent intensity and positive cell
numbers but did not change the trend. It is noted that
the ﬂuorescein-activated cell sorting (FACS) analysis
was performed on BD LSR II analyzer that was set up to
detect emission signals of PE (575/26). This was the
only good channel to detect Cy3 but not the best.
Therefore the real ﬂuorescent intensity or positive cell
percentage would be expected to be higher.
In addition, the successful internalization of Cy3-
labeled oligo DNA-LPMSN-P can also be observed
by confocal microscopy (Figure 6B). The image from
the microscopy shows that most red signals (Cy3) are
within the cells. To further conﬁrm this, we also stained
Figure 6. Assessments of cell uptake by ﬂow cytometry analysis and confocal microscopy. The internalization of Cy3-labeled
oligoDNA-LP-MSN and functionalized counterparts (LP-MSN-A and LP-MSN-P) in HeLa cells were observed by ﬂow cytometry
(A) and confocal microscopy (B). The confocal image shows localization of nanoparticle (LP-MSN-P) delivered oligo-DNA-Cy3
(red color) in HeLa cells, while the nuclear are stained blue (DAPI) and the cell membrane is stained green (FITC).
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the cells with anti-CD24 antibody conjugated with
ﬂuorescein isothiocyanate (FITC). CD24 is a cell mem-
brane protein. It can be seen clearly that most red
signals are separated from green (FITC) though there
are a few colocalization (yellow) cases, suggesting that
most Cy3s are internalized. These results conﬁrm that
LP-MSN-P has the highest cellular uptake compared to
LP-MSN-A and LP-MSNs.
Even though the oligo DNA adsorption study in-
dicates that LP-MSN-A had strong interactions with
oligo DNA, the fact that the LP-MSN-A complex only
generated less signals should (Figure 5 and Figure 6A)
be related to the less eﬀective cell uptake. PLL-functio-
nalization had signiﬁcantly enhanced cell uptake as
compared to the amine functionalization. The en-
hancement is believed to be caused by the favored
interfacial interactions between PLL and the cancer cell
surface. The multiple accessible reactive sites of PLL
not only support the material's interactions with the
oligo DNA but also induce stronger interactions with
the negatively charged cell surface. These strong inter-
actions lead to eﬃcient wrapping of the silica particles
which in turn lead to higher cellular uptake.7 In con-
trast, in the case of LP-MSN-A, the strong interactions
between LP-MSN-A and oligo-DNA result inmost of the
positively charged amines being covered by the DNA.
These results agree well with previous ﬁndings re-
ported by Martin et al. who showed that the functio-
nalization of iron oxide particles with longer chain
molecular structure of guanidine dendron has a
beneﬁcial inﬂuence on cell uptake as compared to
shorter amine dendrons.51 More elongated and ﬂex-
ible dendron structure permittedmore favorable inter-
actions with the cell surface leading to higher cell
uptake.
To conclude, the results of the adsorption and
cell uptake experiments establish that surface modiﬁ-
cation of LP-MSNs is indeed crucial in order to eﬃ-
ciently adsorb and to deliver oligo-DNA into cancer
cells. Our results emphasize the high eﬃciency of
LP-MSN-P in adsorbing oligo DNA as a model for siRNA
and interacting with cancer cells with enhanced cel-
lular uptake. Clearly, cell internalization capability of
LP-MSN-P is far superior to both LP-MSN-A and LP-MSNs.
The high transfection of oligo DNA-LP-MSN-P in a dense
cell population suggests that the LP-MSN-P could truly
be promising as a gene carrier for gene therapy applica-
tions. However, the cytoxocity of the system must ﬁrst
be evaluated (see below).
Cytotoxicity Study. To evaluate the cytotoxicity of the
LP-MSNs, we used a cervical cancer cell line SiHa. The
cell viability test (Figure 7A) results demonstrate that
the toxicity of LP-MSNs and its functionalized forms are
determined by their concentration. The cytotoxicity
was increased as the nanoparticle concentration in-
creased. The results are further confirmed by the
cell images (Figure 7B), i.e., at high concentrations
(>300 μg/mL) all nanoparticles were toxic to some
extent to the cells. However, at lower concentrations
(<100 μg/mL), the three samples had low cytotoxicity.
Figure 7. Cytotoxicity of LP-MSNs and functionalized counterparts. (A) The assay results show the cell viability (%) after 24-h
treatment with diﬀerent doses of LP-MSNs, LP-MSN-A, or LP-MSN-P. (B) Cell (HeLa) images: cytotoxicity comparison between
LP-MSN-A and LP-MSN-P at diﬀerent concentrations. (C) Cell image with LP-MSNs treatment.
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Figure 7 indicates that LP-MSN-P is more toxic than
LP-MSN-A and the native LP-MSNs. The toxicity of
LP-MSN-P is related to the cationic charge from the
primary amine surface groups.52 However, the primary
amine will only start inducing toxicity upon strong
interactions with the cell membrane. As mentioned
above, the molecular structure of PLL yields numerous
accessible primary amine sites from each monomer
moiety present in the polymer structure (lysine).
Although these accessible amine sites have the ad-
vantages of inducing strong interactions with the cell
membrane (leading to high cell uptake), it is also
responsible for increased cytotoxicity.
In light of this cytotoxicity study and in relations to
the application of polycation as gene carriers, it is
therefore very important to moderate the impact of
PLL. One of the methods to achieve this is through a
careful selection of the molecular weight of PLL and
the complex particle concentration. LP-MSN-P materi-
als which was modiﬁed using low molecular weight of
PLL (14 kDa) show high biocompatibility at con-
centrations below <100 μg/mL. Fortunately, the
high loading capacity of siRNA within the LP-MSN-P
will support siRNA eﬃcacy even at a low particle
concentration.
Delivery of siRNA to Cells. To investigate whether the
LP-MSNs system could deliver biofunctional siRNA for
therapeutic applications, we used the nanoparticles to
deliver siRNAs against polo-like kinase 1 (PLK1) and
minibrain-related kinase (Mirk) and tested gene silen-
cing effect in osteosarcoma cell line KHOS cells. These
two oncogenic genes are highly expressed in osteo-
sarcoma cells and silencing them with siRNAs can
inhibit KHOS cell growth.53,54 For control, we chose
another siRNA, S10, which was reported by some of us
as an effective siRNA against human papillomavirus
(HPV) type 16 E6 gene.55 At first, we tested the effec-
tiveness of LP-MNS-A in transferring both PLK1- and
Mirk-siRNAs. As illustrated in Figure 8, compared to
controls (including LP-MSNs alone and S10-siRNA
controls), LP-MSN-A could deliver both PLK1- and
Mirk-siRNAs and induced a noticeable decrease of cell
viability at high siRNA concentrations (100 nM). At this
concentration, LP-MSN-A was able to reduce cell via-
bility by around 15%. LP-MSN-P was then also tested to
deliver PLK1 siRNA. The positive control of LP-MSN-A
and LP-MSN-P shows that the particle toxicity contrib-
uted to mild decrease of cellular viability namely 5%
and 10% for LP-MSN-A and LP-MSN-P, respectively.
Most importantly, LP-MSNP-P showed a better perfor-
mance compared to LP-MSN-A by revealing higher
reduction of cellular viability at 30% which is double
than that of LP-MSN-A.
One of the reasons of the observed higher gene
expression of LP-MSN-P compared to LP-MSN-A is the
high cell uptake of LP-MSN-P. Themain prerequisite for
siRNA to express their biofunction is by transferring the
siRNA into the cytoplasm.4,56 Increase in cell uptakewill
lead to an increased delivery of siRNA into the cyto-
plasm. Furthermore, it has been reported that PLL can
cause the fusion of the membrane leading to the
destabilization of the endosomonal membrane.24,57,58
The presence of PLL could thus boost endosomonal
break out of the particles which ultimately increases
particle release into the cytoplasm. In turn, these two
factors (high cell uptake and endosomonal escape) are
believed to increase siRNA accumulation within the
cytoplasm and enhance the gene silencing eﬀect.
However, knockdown of oncogenes still need to be
improved. The general problem with the polycation as
siRNA carrier is the less eﬃcient release of siRNA from
the complex. Polycations (PLL, PEI) have strong aﬃnity
toward genes (siRNA/DNA). It is known that the strong
interactions between carriers and genes could lead to a
diﬃcult disassembling of the biological molecules,
which in turn aﬀects the knock down eﬃciency/gene
Figure 8. Biological function analysis of LP-MSNs and functionalized counterparts by delivering siRNAs. The LP-MSN-P and
LP-MSN-A were loaded with functional siRNA against oncogenes PLK and Mirk that are overexpressed in osteosarcoma cell
line KHOS. Three siRNA loading concentrations (25, 50, and 100 nM)were tested. Positive control was the cell viabilitywithout
any siRNA and particle treatment. S10-siRNA was used as a negative control: (A) LP-MSN-P; (B) LP-MSN-A. The P values are
from Student's t test.
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silencing.59 One of the most important phases in drug/
gene delivery into cells is the so-called vector unpacka-
ging. The problematic part is to design a carrier which
has strong aﬃnity versus siRNA, yet the bonding
between them should not limit the disassembly of
siRNA from the LP-MSNs once the complex get into
the cell cytoplasm. To overcome the current LP-MSN-P
limitation, further studies are still needed to conﬁrm
the possibility for substituting PLL with more degrad-
able polycations or other polymers. A degradable
structure is expected to enhance siRNA release from
the polymer and also reduce the associated toxicity.
Another issue for in vivo application of LP-MSN-P
is colloidal particle stability. Our study indicates that
LP-MSN-P shows better performance compared to
LP-MSN-A in terms of dispersibility (Supporting Infor-
mation, Figure S5) andminor aggregation of LP-MSN-P
was observed. This minor aggregation might lower the
eﬀectiveness of LP-MSN-P as a siRNA carrier because
the aggregate particles have shorter in vivo circulation
time as compared to well-dispersed particles. Further
work is underway to perform optimization of the
LP-MSNs system, including optimizing PLL concentration
to achieve electrostatic stability and introducing poly-
(ethylene glycol) (PEG) on the particle's surface to
induce “stealth” properties thus improving the parti-
cle's circulation time.
CONCLUSIONS
We demonstrated in this study that functionalized
large pore mesoporous silica nanoparticles with cubic
mesostructure have a true potential for delivery of
nucleic acids in high concentration. The PLL functio-
nalized LP-MSNs have a strong binding capacity to
negatively charged nucleic acid while creating
strong interactions with the negatively charged cell
surface membrane. As a result, cellular uptake is
enhanced. The nanoparticles had an excellent rate
of cells transfection in which most of the cells in the
population have been aﬀected. The use of large
pores clearly improved adsorption of oligo DNA (a
DNA model for siRNA). The adsorbed amount
achieved was signiﬁcantly higher compared to small
pore size mesoporous silica nanoparticles reported
previously. Moreover, PLL functionalization showed
superior cancer cell transfection compared to amine-
functionalized equivalents. The functionalized nano-
particles showed low cytotoxicity at concentrations
up to 100 μg/mL. Furthermore, a reasonable reduc-
tion of cellular viability of oncogenes in cancer cells
has been demonstrated by delivery of siRNA using
the PLL functionalized LP-MSNs. Therefore, we have
designed nanostructured vector carriers with large
internal pore space enabling the inclusion of various
biomolecules and possessing adequate surface func-
tionalization suitable for dual delivery of drug and
genes. In addition to the therapeutic reagents, the
large pores of the LP-MSNs may also be used to
simultaneously host speciﬁc contrast agents (e.g.,
MRI tracking), optical probes, or magnetic nanopar-
ticles for future targeted delivery and theranostic
applications.
MATERIALS AND METHODS
Chemicals. Triblock poly(ethylene oxide)-b-poly(propylene
oxide)-b-poly(ethylene oxide) copolymer EO106PO70EO106
(pluronic F127, MW = 13400), tetraethoxysilane (TEOS, 99%),
1,3,5-trimethylbenzene (TMB), 3-aminopropyltriethoxysilane
(APTES, 99%), 3-glycidoxypropyl trimethoxysilane (3-GPS), and
poly-L-lysine (PLL) were purchased from Sigma Aldrich. Fluor-
ocarbon surfactant (FC-4) was purchased from Yick-Vic Chemi-
cals & Pharmaceuticals (H.K.) Ltd. All chemicals were used as
received without purification. Cell lines used including cervical
cancer cell lines HeLa (ATCC, CCL-2), SiHa (ATCC, HTB-35)
cells, and osteosarcoma cell line KHOS/NP (CRL-1544) were
purchased from ATCC (American Type Culture Collection).
Twenty-one-nucleotide (oligo) DNA conjugated with cyanine
dye (Cy-3), fetal calf serum, paraformaldehyde, and antifade
fluorescent mounting mediumwith 40-6-diamidino-2-phenylin-
dole (DAPI) were purchased from Sigma Aldrich. Dulbecco's
Modified Eagle's Medium (DMEM) and penicillin G, strepto-
mycin sulfate, and L-glutamine mixture were from Gibco-
Invitrogen. CellTiter-Glo cell viability assay kit was from
Promega. Synthetic human PLK1 and Mirk siRNAs were pur-
chased from Ambion at Applied Biosystems (Foster City, CA).
The siRNA sequences are PLK-S, 50-CCAUUAACGAGCUG-
CUUAATT-30 ; PLK-AS, 50-UUAAGCAGCUCGUUAAUGGTT-30 ;
Mirk-S, 50-GGCACUUCAUGUUCCGGAATT-30 ; Mirk-AS, 50-UUC-
CGGAACAUGAAGUGCCGC-30 . S10-siRNA was synthesized by
Proligo (Lismore, Australia) and the sequences are as follows:
S10-S, 50-GCAACAGUUACUGCGACGUUU-30 ; S10-AS, 50-AC-
GUCGCAGUAACUGUUGCUU- 30 .
Synthesis of LP-MSNs. The synthesis of LP-MSNs with cubic
mesostructure followed themethod previously reported byGao
et al.15 First, 0.5 g of F127 and 1.4 g of FC-4 were dissolved in
60 mL of 0.02 M HCl and stirred for 24 h at 60 C. A 0.4 g portion
of TMB was added into the mixture and stirred at a low
temperature of 10 C for 6 h. Then, 3 g of TEOS was added to
the solution, and the stirring process at 10 C was continued for
another 24 h. The solution was then transferred into autoclaves
for the hydrothermal treatment. The first hydrothermal tem-
perature was at 150 C for 24 h which then followed by second
hydrothermal treatment at 140 C for 48 h. The sample was
denoted as LP-MSNs.
Epoxysilane (3-GPS) Functionalized LP-MSNs (LP-MSN-E). A 300 mg
portion of LP-MSNs was added into 25 mL of toluene. The
mixture was first sonicated to facilitate dispersion, then 0.4 mL
of 3-GPS was added. After 15 min, the mixture was refluxed at
70 C for 24 h. The solid products were centrifuged, washedwith
toluene and methanol for three times, and dried. The sample
was denoted as LP-MSN-E.
PLL Functionalized LP-MSNs (LP-MSN-P). To prepare PLL-functio-
nalized LP-MSNs, a stock solution of PLL and LP-MSN-E was first
prepared. The concentration of PLL in carbonate buffer solution
(50 mM, pH 9.5) was 5 mg/mL, while the LP-MSN-E solution was
prepared at 10mg/mL in the same buffer solution. Then, 2mL of
PLL peptide solution was mixed with 4 mL of the LP-MSN-E
solution. The mixture solution was stirred at room temperature
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for 24 h. After this step, the solid product was produced and
washed with 20 mL of 1.0 M NaCl and water, and then
centrifuged. At the final stage, the solid products were sus-
pended in 20 mL of 1.0 M ethanolamine (pH 9) and stirred at
room temperature for 6 h to block unreacted epoxy groups. The
solids were then again washed with 20 mL of 1.0 M NaCl and
20 mL of water. The sample was denoted as LP-MSN-P.
Amine-Functionalized LP-MSNs (LP-MSN-A). One gram of LP-MSNs
was dispersed in 50 mL of toluene. The mixture was first
sonicated to facilitate dispersion. It was heated to 50 C, then,
1 mL of APTES was added and heated to 110 C. The reflux
process was continued for 16 h. The solid products were
collected via the centrifuge and washed 5 times with acetone
to remove toluene. The sample was then dried in oven at 50 C
and denoted as LP-MSN-A.
Oligo DNA Adsorption into LP-MSNs and Functionalized LP-MSNs. The
adsorption isotherm was determined by preparing a series of
oligo DNA solutions with various concentrations ranging from
40 to 650 μg/mL in PBS buffer at pH 7.4. As much as 1 mg of
LP-MSNs was thenmixed with 250 μL of each oligo DNA solutions
in 1.5 mL centrifuge tube. The mixture was dispersed by vortex
for 30 s and incubated in a shaker with a 200 rpm shaking speed
at 25 C for 24 h. Suspensions were separated by centrifugation
at 14 800 rpm for 5min. The difference of the oligo DNA amount
in solution before and after adsorption was deemed equal to
the amount of oligo DNA adsorbed on the material.
Cell Uptake Assay. The assays were carried out in 6-well cell
culture plates. HeLa cells were seeded in plates at 2  105 cells
per well the day before the assay. The particles (LP-MSNs,
LP-MSN-P, and LP-MSN-A) were diluted in phosphate buffered
saline (PBS) at a concentration of 1 mg/mL, and 100 μL of the
resulting mixture was used for each well. A 21-nucleotide long
(oligo) DNA conjugated with cyanine dye (Cy-3) was used as a
template for short interfering RNA (siRNA) and was diluted in
the 100 μL of particle solution to give final oligo DNA concen-
trations of 50 nM and 100 nM. The solution was mixed well and
incubated at room temperature for 4 h or overnight at 4 C. After
incubation, the particles were washed once with PBS, then
centrifuged 3 min at 3000 rpm on a desktop microcentrifuge
followed by two washes with Dulbecco's Modified Eagle's
Medium (DMEM) supplementedwith 10%heat-inactivated fetal
calf serum, 100 units/mL penicillin G, 100ug/mL streptomycin
sulfate, and 0.29 mg/mL of L-glutamine (Gibco-Invitrogen), the
complete DMEM. The nanoparticles were resuspended in
100 μL of complete DMEM and added to each well of 6-well
plates containing 1 mL of complete DMEM. After 4 h of
incubation at 37 C, the cells were washed 2 times with PBS
and fixed with 4% paraformaldehyde in PBS (4 C for 30 min).
The cells were washed again with PBS and the liquid was
drained. A 200 μL portion of antifade fluorescent mounting
mediumwith DAPI was added in for staining the nuclei, and the
cells were viewed under the fluorescent microscopy.
CD24 Staining. The nanoparticle-treated cells were fixed with
4% PFA/PBS in 6-well plates and harvested by trypsinisation.
The cells were washed once in PBS and resuspended in 200 μL
CD24 staining buffer and incubated for 1 h at room tempera-
ture. The staining buffer contains 0.1% (w/v) BSA (bovine serum
albumin) and 5 μL monoclonal antihuman CD24 antibody-FITC
(BD, Australia) in PBS. The cells were washed three times with
PBS and mounted onto slide by Cytospin 4 (Thermo Shandon).
The cells were viewed using a confocal microscopy.
Quenching Oligo-DNA-Cy3 with DNase I. The nanoparticle treated
cells were directly harvested by trypsination followed by one
wash in PBS. The cells were fixedwith 2%PFA/PBS at 4 C for 2 h.
The fixed cells were then divided into two halves. One half was
for direct FACS analysis and the other half for DNase I treatment.
For this treatment the cells were washed once in PBS, and the
cell pellet was resuspended in 500 uL treatment solution, which
contains 1 mM CaCls, 0.5 mM MgCl2, 0.1 (w/v) BSA, and 120
Units of DNase I (Sigma, Australia) in PBS. After 30 min incuba-
tion at room temperature, the cells were washed for 3 times
with PBS and resuspended in 2% PFA/PBS for FACS analysis
using BD LSR II analyzer (BD, Australia) and the results were
analyzed using software FlowJo
Cytotoxicity of the Particles. The cervical cancer cell line SiHa
was used for cytotoxicity test as it grows slower than HeLa cells.
The cells were seeded in 96-well plates at 1  104 cells/well for
24 h before the testing. The particles (LP-MSNs, LP-MSN-P, and
LP-MSN-A) were diluted in 2-fold series in the complete DMEM
medium such as 1:20, 1:40, 1:80, and so on, and 100 μL of each
dilution was added to the cells. After 24 h of incubation at 37 C,
the treatment was stopped by washing the cells three times
with freshmedium. The cells were cultured for another 24 h and
the cytotoxicity was measured using Cell-Titer Glo method (Cell
viability Luminescent Assay Kit, CellTiter-Glo, Promega) accord-
ing to the instruction of the manufacturer .
Biological Function Assay for Delivering Functional siRNA. To exam-
ine whether the particles (LP-MSN-P and LP-MSN-A) can deliver
functional molecules to cells for therapy, we chose siRNAs
against Mirk and PLK1 genes. S10-siRNA which is effective
against human papillomavirus (HPV) type 16 E6 gene was used
as control. There is no HPV in KHOS cells therefore it can be used
as negative control. The cells were seeded at 800010000 cells/
well in 100 μL of complete DMEM medium in 96-well plate and
culture for overnight before treatment. The siRNAs were ab-
sorbed to particles as described above for 21-nucleotide oligo
DNA andwere added to the cells. The cells were treated for 48 h
and the silencing effect or cell viability was determined by Cell-
Titer-Glo assay.
Characterization. TEM images were obtained by a JEOL 2100
electron microscope with an acceleration voltage 200 kV. SEM
images were recorded on a JEOL 6300 microscope operated at
510 kV. Nitrogen sorption isotherms of the samples were
obtained at 196 C (77 K) using a Quantachrome's Quad-
rasorb SI analyzer. Before the measurements, the sam-
ples were degassed overnight in vacuum. The Brumauer
EmmettTeller (BET) surface area was calculated using ex-
perimental points at a relative pressure of P/P0 = 0.050.25.
The total pore volume was calculated from the N2 amount
adsorbed at the highest P/P0 (P/P0 = 0.99). The pore size
distribution was calculated by the Broekhoffde Boer (BdB)
method using a spherical model. The cavity pore size and
entrance pore size are determined from the adsorption and
desorption branches, respectively, using the BdB method. XPS
spectra were recorded on a Kratos Axis Ultra with a mono-
chromatic Al KR X-ray source. Each spectrum was recorded at a
survey scan from 0 to 1200 eV with a dwell time of 100 ms, pass
energy of 160 eV at steps of 1 eVwith 1 sweep. A high resolution
scan was conducted at a lower pass energy (20 eV), higher
sweep and dwell time at 250 ms. C1s with a binding energy of
285 eV was used as the reference. The atomic ratio of LP-MSNs
and their functionalized forms (LP-MSN-E, LP-MSN-P, and
LP-MSN-A) were determined from XPS spectra. Solid state
magic-angle spinning (MAS) 13C nuclear magnetic resonance
(NMR) measurements were performed with a Bruker MSL-300
spectrometer operating at a frequency of 75.482 MHz for 13C.
The spectrometer was equipped with a 4-mm double air
bearing, magic angle spinning probe for MAS experiments. The
proton 90 pulse time used in the CPMAS method was 5.5 μs,
the acquisition time was 45 ms, cross-polarization time was
2ms, and the relaxation delay was 3 s. The spectrumwidth was
50 kHz, and 4000 data points were collected over 2000 scans.
The chemical shift of the 13C spectrum was referenced to the
resonance of adamantine at 38.23 ppm. All samples were
equilibrated at room temperature (22 C). Zeta potential
measurements and Dynamic Light Scattering (DLS) were
carried out by using a Zeta Sizer Nano-SZ from Malvern
Instrument. LP-MSNs were suspended in PBS buffer (pH 7.4)
at a concentration of 0.5 mg/mL. The samples were mixed well
by sonication and vortex before analysis. Fourier transformed
infrared spectra were measured on a Nicolet 6700 FTIR;
32 scans were collected at a resolution of 4 cm1. TGA/DSC 1
(Mettler-Toledo AG) was used for TGA at a heating rate of
2 C/min under a nitrogen flow of 20 mL/min. Small-angle
X-ray scattering (SAXS) was performed using an Anton-Parr
SAXSess small-angle X-ray scattering system (Cu KR radiation,
40 kV, 35 mA).
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Figure S1. Nitrogen sorption isotherms (top) and pore size distributions (PSD) (bottom) of LP-MSNs,  
LP-MSN-P and LP-MSN-A. For improved clarity, isotherms LP-MSN-P and LP-MSN-A are shifted 
vertically by 400 and 700 cc STP/g 
S3 
 
 
 
Figure S2. SAXS pattern of LP-MSNs.  Inset is a TEM image showing the cubic structure of LP-MSNs.  
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Figure S3. TGA analyses of (A) LP-MSNs, (B) LP-MSN-E, (C) LP-MSN-P and (D) LP-MSN-A 
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Figure S4. FTIR spectra of LP-MSNs, LP-MSN-E and LP-MSN-P. 
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Figure S5. Nanoparticle size distributions obtained by DLS for LP-MSNs, LP-MSN-P and LP-MSN-A 
(A) after mixing and (B) one hour after mixing.  
 
We measured the hydrodynamic size of LP-MSNs after mixing and one hour after mixing, to determine 
the silica stability in PBS buffer. The stability test indicated that LP-MSN-P were more stable compared 
to LP-MSN-A.  
The aggregation tendency of LP-MSN-A can be seen directly even right after mixing (Figure S5 A). The 
mean hydrodynamic size of LP-MSNs, LP-MSN-P and LP-MSN-A were 205 nm, 334 nm and 419 nm, 
S6 
 
respectively. After one hour mixing, there were no substantial changes in hydrodynamic size for LP-
MSNs and LP-MSN-P. The particle size of LP-MSNs was around 216, while LP-MSN-P’s size was 
around 340. In contrary, pronounced aggregation of the LP-MSN-A particles was observed and their 
mean particle size increased quite significantly to 587 nm.  
Previous research indicated that amine-silane functionalized silica tended to aggregate. 1, 2 The main 
reason for the amine’s aggregation was attributed to the effect of “back bonding” where amine moieties 
interacted with the negatively charged of silanol group on the silica surface.1 However, in of the case of 
the LP-MSN-P, we believe that the 3-D elongated structures of PLL make amine moieties away from the 
silanol groups (only the amine moieties that lie very close to the silanol groups undergo the back 
bonding) and thus can maintain proper electrostatic repulsion. As a result, the aggregation of LP-MSN-P 
can be minimized and the particle dispersability can be maintained.  
1. Bagwe, R. P.; Hilliard, L. R.; Tan, W. Surface Modification of Silica Nanoparticles to Reduce 
Aggregation and Nonspecific Binding. Langmuir 2006, 22, 4357-4362. 
2. Kim, M.-H.; Na, H.-K.; Kim, Y.-K.; Ryoo, S.-R.; Cho, H. S.; Lee, K. E.; Jeon, H.; Ryoo, R.; 
Min, D.-H. Facile Synthesis of Monodispersed Mesoporous Silica Nanoparticles with Ultralarge Pores 
and Their Application in Gene Delivery. ACS Nano 2011, 5, 3568-3576. 
 
 
